Our strategic research pillars are:
- To prevent mother to child hepatitis B transmission and improved vaccination coverage
- To improve hepatitis B testing, linkage to care and treatment uptake to achieve WHO 2030 hepatitis B elimination targets
- To increase prevention and early diagnosis of primary liver cancer
Our team have expertise in mathematical modelling, novel diagnostics development, epidemiology, health systems intervention trials and qualitative methods.
Our hepatitis B and liver cancer research programs leverage our unique cross-centre partnership with St Vincent’s Hospital/ University of Melbourne and global collaborations to achieve maximal clinical impact.
Associate Professor Jessica Howell
Jessica is consultant gastroenterologist at St Vincent's Hospital and The Royal Melbourne Hospital, with a research interest in liver cancer and viral hepatitis.
Meet the working group. Together, we are translating research into better health, for all.